DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Pharmaceuticals & Biotech
Updated 10m ago
CALI

FinCanna Capital Corp.CNSX:CALI.X Stock Report

Market Cap CA$5.0m
Updated 10m ago
Share Price
n/a
1Y0%
7D0%
Portfolio Value
​
View

FinCanna Capital Corp.

CNSX:CALI.X Stock Report

Market Cap: CA$5.0m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

FinCanna Capital (CALI.X) Stock Overview

Does not have significant operations. More details

CALI.X fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Rewards

Trading at 42.1% below our estimate of its fair value

Earnings have grown 39.8% per year over the past 5 years

Risk Analysis

Shares are highly illiquid

Negative shareholders equity

Does not have a meaningful market cap (CA$5M)

Makes less than USD$1m in revenue (CA$-486K)

+ 1 more risk

CALI.X Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW423,602 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
423,602 investors already sharing narratives
CA$
Current Price
CA$0.005n/aintrinsic discount
Est. Revenue
$
PastFuture-12m2m2016201920222025202620282031Revenue CA$0.7Earnings CA$0.1
Advanced
View all narratives

FinCanna Capital Corp. Competitors

SOL Global Investments

Symbol: CNSX:SOL
Market cap: CA$1.1m

Herbal Dispatch

Symbol: CNSX:HERB
Market cap: CA$3.9m

Nextleaf Solutions

Symbol: CNSX:OILS
Market cap: CA$6.0m

Delivra Health Brands

Symbol: TSXV:DHB
Market cap: CA$3.4m

Price History & Performance

Summary of share price highs, lows and changes for FinCanna Capital
Historical stock prices
Current Share PriceCA$0.005
52 Week HighCA$0.005
52 Week LowCA$0.005
Beta2.87
1 Month Change0%
3 Month Changen/a
1 Year Change0%
3 Year Change0%
5 Year Change-99.17%
Change since IPO-99.96%

Recent News & Updates

Recent updates

Shareholder Returns

CALI.XCA PharmaceuticalsCA Market
7D0%-1.2%-1.6%
1Y0%6.9%21.9%

Return vs Industry: CALI.X exceeded the Canadian Pharmaceuticals industry which returned -8.3% over the past year.

Return vs Market: CALI.X underperformed the Canadian Market which returned 19.5% over the past year.

Price Volatility

Is CALI.X's price volatile compared to industry and market?
CALI.X volatility
CALI.X Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement8.1%
Market Average Movement9.1%
10% most volatile stocks in CA Market16.1%
10% least volatile stocks in CA Market3.6%

Stable Share Price: CALI.X's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: Insufficient data to determine CALI.X's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/aVern Vipuln/a

FinCanna Capital Corp. does not have significant operations. Previously, the company provided financing for companies operating in the cannabis sector. FinCanna Capital Corp. is headquartered in Vancouver, Canada.

FinCanna Capital Corp. Fundamentals Summary

How do FinCanna Capital's earnings and revenue compare to its market cap?
CALI.X fundamental statistics
Market capCA$4.99m
Earnings (TTM)-CA$331.14k
Revenue (TTM)n/a
-10.3x
P/S Ratio
-15.1x
P/E Ratio

Is CALI.X overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CALI.X income statement (TTM)
Revenue-CA$485.75k
Cost of RevenueCA$0
Gross Profit-CA$485.75k
Other Expenses-CA$154.61k
Earnings-CA$331.14k

Last Reported Earnings

Jan 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.00033
Gross Margin100.00%
Net Profit Margin68.17%
Debt/Equity Ratio-89.2%

How did CALI.X perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/03 10:34
End of Day Share Price 2025/09/05 00:00
Earnings2025/01/31
Annual Earnings2024/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

FinCanna Capital Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siddharth RajeevFundamental Research Corp.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide